High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide

by Maryam Pourabdollah, Mohammad Bahmanyar, Eshetu G. Atenafu, Donna Reece, Jian Hou, Hong Chang
Published 2016-11-01

Computerized cognitive training in post-treatment hematological cancer survivors: a feasibility study

by Samantha J. Mayo, Sean B. Rourke, Eshetu G. Atenafu, Rita Vitorino, Christine Chen, John Kuruvilla
Published 2021-01-01

Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy

by Lalit Saini, Jack T Seki, Deepali Kumar, Eshetu G Atenafu, David EC Cole, Betty YL Wong, Andrea Božović, Joseph M Brandwein
Published 2014-01-01

Clinical Variables Associated with PSA Response to Lutetium-177-PSMA ([177Lu]-PSMA-617) Radionuclide Treatment in Men with Metastatic Castration-Resistant Prostate Cancer

by Moran Gadot, Tima Davidson, Margalit Aharon, Eshetu G. Atenafu, Avraham Malki, Meital Levartovsky, Akram Saad, Liran Domachevsky, Raanan Berger, Raya Leibowitz
Published 2020-04-01

Reference intervals for hemoglobin and mean corpuscular volume in an ethnically diverse community sample of Canadian children 2 to 36 months

by Jemila S. Hamid, Eshetu G. Atenafu, Cornelia M. Borkhoff, Catherine S. Birken, Jonathon L. Maguire, Mary Kathryn Bohn, Khosrow Adeli, Mohamed Abdelhaleem, Patricia C. Parkin
Published 2021-05-01

ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastoma

by Pejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, Aimee KM Chan, Max Wintermark, Chris Heyn, John Conklin, Benjamin M. Ellingson, Saba Rahimi, Angus Z Lau, Chia-Lin Tseng, Hany Soliman, Jay Detsky, Shadi Daghighi, Julia Keith, David G. Munoz, Sunit Das, Eshetu G. Atenafu, Nir Lipsman, James Perry, Greg Stanisz, Arjun Sahgal
Published 2021-04-01